Brandt MR

References (2)

Title : The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitors - Zhu_2020_Bioorg.Med.Chem.Lett_30_127243
Author(s) : Zhu B , Connolly PJ , Zhang YM , McDonnell ME , Bian H , Lin SC , Liu L , Zhang SP , Chevalier KM , Brandt MR , Milligan CM , Flores CM , Macielag MJ
Ref : Bioorganic & Medicinal Chemistry Lett , 30 :127243 , 2020
Abstract :
PubMedSearch : Zhu_2020_Bioorg.Med.Chem.Lett_30_127243
PubMedID: 32527545
Gene_locus related to this paper: human-MGLL

Title : Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor - Wyatt_2020_J.Pharmacol.Exp.Ther_372_339
Author(s) : Wyatt RM , Fraser I , Welty N , Lord B , Wennerholm M , Sutton S , Ameriks MK , Dugovic C , Yun S , White A , Nguyen L , Koudriakova T , Tian G , Suarez J , Szewczuk L , Bonnette W , Ahn K , Ghosh B , Flores CM , Connolly PJ , Zhu B , Macielag MJ , Brandt MR , Chevalier K , Zhang SP , Lovenberg T , Bonaventure P
Ref : Journal of Pharmacology & Experimental Therapeutics , 372 :339 , 2020
Abstract :
PubMedSearch : Wyatt_2020_J.Pharmacol.Exp.Ther_372_339
PubMedID: 31818916